Stroke
Conditions
Interventions
Control group: Included functional limb positioning, muscle activation training, core stability training, balance training, activities of daily living (ADL) simulation, and low-frequency electrical st
pulse width: 0.5 ms
frequency: 60–80 Hz) to Futu-Liangqiu, Jimen-Xuehai, and Zusanli-Jiexi pairs at tolerable intensity. Needles were retained for 30 min. After needle removal, patients assumed lateral decubitus position
Mangxin group: In supine position, 70-mm elongated needles transfixing Futu-Liangqiu, Jimen-Xuehai, and Zusanli-Jiexi pairs were manipulated with high-frequency, low-amplitude rotation. Standard 40-mm
Sponsors
Shandong Third Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Chinese medicine diagnostic criteria: refer to the "Diagnostic and therapeutic evaluation criteria of stroke disease" (for trial implementation) formulated by the National Science and Technology Commission's research project "85-919-02-01" in 1996; 2. Western medicine diagnostic criteria: refer to the "China Acute Ischemic Stroke Diagnostic Guidelines 2010" and "China Cerebral Hemorrhage Diagnostic Guidelines ( 2014)"; 3. (2014); 3. Cerebral infarction or cerebral hemorrhage was diagnosed clinically and by cranial CT or MRI, and it was the first time onset of the disease, and the duration of the disease was = grade 3; 5. There were no patients with acute critical illness, chronic debilitating disease, contact infectious disease, hematological disease, and psychiatric disease; 6. The patients gave their informed consent, had a good compliance, and voluntarily accepted the observation of this clinical trial. accept the observation of this clinical trial.
Exclusion criteria
Exclusion criteria: 1. those who did not meet the inclusion criteria; 2. those with comorbid neurological or musculoskeletal disorders affecting functional recovery; 3. those with low cognitive function; 4. those with severe cardiac, pulmonary, hepatic, renal, and hematopoietic disorders; and 5. those who wore cardiac pacemakers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Berg balance scale score;Modified Barthel index;Timed up and go test;Gait; | — |
Countries
China
Contacts
Public ContactWang Xin
Shandong Third Hospital
Outcome results
None listed